Inappropriate ADH Syndrome: all 41 studies
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid RestrictionRecruitingNCT07528365Not applicable
- Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable
- Low-dose Tolvaptan for Inpatient Hyponatraemia.RecruitingNCT06171100
- Urea for Chronic HyponatremiaTerminatedNCT04588207Phase 2Results posted
- A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHCompletedNCT03048747Phase 3Results posted
- An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in SpainCompletedNCT02548845Results posted
- An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADHCompletedNCT02545101Results posted
- A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)CompletedNCT02009878Phase 1/2Results posted
- Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional HyponatremiaTerminatedNCT01227512Phase 3Results posted
- Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIADCompletedNCT06277336Not applicable
- Asymptomatic Bacteriuria, Hyponatremia and Geri-atric SyndromeCompletedNCT05055856Not applicable
- Effect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIADCompletedNCT04987385Not applicable
- Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADHActive, not recruitingNCT04790175
- Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic HyponatremiaCompletedNCT04744987
- Urea Therapy for Hyponatremia in Subarachnoid HemorrhageActive, not recruitingNCT04552873Not applicable
- Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT04447911Phase 4
- Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference StudyStatus unknownNCT04409626
- Water Load Test Value for HyponatremiaCompletedNCT04256499
- Tolvaptan Versus Fluid Restriction in SIADHCompletedNCT04119206
- SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric PatientsCompletedNCT03924674Not applicable
- Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx StudyCompletedNCT03202667Phase 2/3
- Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND StudyCompletedNCT02874807Phase 2/3
- Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyCompletedNCT02729766Phase 2/3
- An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in ItalyCompletedNCT02573077
- Tolvaptan for Patients With Acute Neurological InjuriesTerminatedNCT02545114Not applicable
- The Clinical and Laboratory Characteristics of Recurrent Drug- Related HyponatremiaStatus unknownNCT01509170
- Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water HomeostasisCompletedNCT01465672
- Fractional Urate Excretion in Nonedematous HyponatremiaWithdrawnNCT01425125Not applicable
- Tolvaptan for In-hospital HyponatremiaTerminatedNCT01386372Phase 2
- Subclassification of the Syndrome of Inappropriate ADH SecretionCompletedNCT01341665
- Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain InjuryCompletedNCT01313975
- Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeStatus unknownNCT01228682
- International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430CompletedNCT01056848
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic HyponatremiaCompletedNCT00876798Phase 3
- A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaTerminatedNCT00728091Phase 3
- The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)CompletedNCT00390962
- Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00264927Phase 3
- Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00264914Phase 3
- Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00201994Phase 3
- "SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00072683Phase 3
- Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00032734Phase 2